Thymoglobulin

also known as ATG

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT00822770 Background	Jan 2009 → Oct 2012	disease related to hematopoietic stem cell transplant, leukemia	M.D. Anderson Cancer Center	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Thymoglobulin	“ATG (Thymoglobulin)” NCT00822770 ↗
Known as	ATG	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00822770 ↗
Route	Intravenous	“If your stem cell donor is not someone who is related to you, you will receive antithymocyte globulin (ATG) through the CVC once a day from Day -3 through Day -1.” NCT00822770 ↗